AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $22.33 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.